On 31 December 2019, a cluster of pneumonia cases of unknown aetiology was reported in Wuhan, Hubei Province, China. On 9 January 2020, China CDC reported a novel coronavirus (2019-nCoV) as the causative agent of this outbreak, which is phylogenetically in the SARS-CoV clade.
As of 26 January 2020, a total of 2 026 laboratory-confirmed 2019-nCoV cases have been reported, 1 988 in China and 38 imported cases from other countries around the world. Fifty six deaths have been reported among the cases. Chinese health authorities have confirmed human-to-human transmission outside Hubei province and 16 healthcare workers are reported to have been infected.
A novel coronavirus (2019-nCoV) has been isolated and considered the causative agent of the cluster of 448 pneumonia cases in the area of Wuhan, Hubei province in China, as well as of the four travel-associated cases in Thailand, Japan and South Korea.
A novel coronavirus (2019-nCoV) has been isolated and considered the causative agent of the cluster of 41 pneumonia cases in the area of Wuhan, Hubei province in China, as well as of the three travel-related cases in Thailand and Japan, arriving from Wuhan.
Between 31 December and 5 January, 59 pneumonia cases possibly associated with a novel coronavirus have been reported in Wuhan, China with a common exposure link to Wuhan’s South China Seafood City market.
This situation update for seasonal influenza uses epidemiological and virological data to assess the seasonal increase of influenza cases in relation to disease severity and impact on healthcare systems. It is designed to assist forward planning in Member States.
Spanish authorities have reported the likely sexual transmission of dengue between two men. One of the men travelled to Cuba and the Dominican Republic (both countries where dengue is endemic) and returned to Spain on 4 September 2019.
In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.
In April 2019, Finland reported false-negative or equivocal results in patients tested for Chlamydia trachomatis (CT) using Aptima Combo 2 Assay (Hologic) (AC2).
This report assesses the risk of invasive pulmonary aspergillosis (IPA) among patients with severe influenza in hospital intensive care units in the European Union (EU)/European Economic Area (EEA)